Electronic Journal of General Medicine

• Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981;2(8259):1303-10.
• Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67(5):968-77.
• Wu G, Wei G, Huang J, Pang S, Liu L, Yan B. Decreased gene expression of LC3 in peripheral leucocytes of patients with coronary artery disease. Eur J Clin Invest 2011;41(9):958-63.
• Şatıroğlu Ö, Vural M, Uyar İ, Meriç M. Focal myocarditis mimicking acute St-elevation myocardial infarction. Nobel Med 2011;7(1):119-23.
• Muller, II, Muller KA, Schonleber H, et al. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PloS One 2012;7(6):e38376.
• Baetta R, Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis 2010;210(1):1-13.
• Steptoe A, Wikman A, Molloy GJ, Kaski JC. Anaemia and the development of depressive symptoms following acute coronary syndrome: longitudinal clinical observational study. BMJ Open 2012;2(1):e000551.
• Gensini G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
• Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007;192(2):328-34.
• Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106(23):2894-900.
• Rotzius P, Thams S, Soehnlein O, et al. Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice. Am J Pathol 2010;177(1):493-500.
• Zernecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008;102(2):209-17.
• Soehnlein O, Drechsler M, Hristov M, Weber C. Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis. J Cell Mol Med 2009;13(11- 12):4293-303.
• Ricevuti G, Mazzone A, De Servi S, Specchia G, Fratino P. New trends in coronary artery disease: the role of granulocyte activation. Atherosclerosis 1989;78(2-3):261-5.
• Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44(10):1945-56.
• Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 2004;175(1):151-7.
• Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. The Am J Cardiol 1984;53(8):997-9.
• Linden MD, Furman MI, Frelinger AL, et al. Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost 2007;5(4):761-5.
• Valente S, Lazzeri C, Saletti E, Chiostri M, Gensini GF. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence. J Cardiovasc Med (Hagerstown) 2008;9(11):1083-7.
• Kaya MG YR, Okyay K, et al. Relationship between plasma myeloperoxidase level and extent of coronary artery involvement and early prognosis in acute ST elevation myocardial infarction. Med Invest J (Turkish) 2005;3(3):27-31.
• Kocaman SA, Tacoy G, Sahinarslan A, Cengel A. Relationship between total and differential leukocyte counts and isolated coronary artery ectasia. Coron Artery Dis 2008;19(5):307- 10.
• Lee WH, Lee Y, Jeong JO, Lee SY, Choi YH, Park JE. Activation of CD14 on circulating monocytes in patients with acute coronary syndrome. Int J Cardiol 2001;80(2-3):135-42.
• Knuefermann P, Nemoto S, Misra A, et al. CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation 2002;106(20):2608-15.
• Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996;183(3):949-58.
• Mizoguchi E, Orihara K, Hamasaki S, et al. Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina. Coron Artery Dis 2007;18(1):31-8.
• Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321(5):280-7.
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352(16):1685-95.
• Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008;8(10):802-15.
• Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004;172(1):1-6.
• Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000;102(19):2329-34.
• Pellizzon GG, Dixon SR, Stone GW, et al. Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). Am J Cardiol 2003;91(6):729-31.
• Aalto K, Honkanen V, Lahdenne P. Iron status during antiTNF therapy in children with juvenile idiopathic arthritis. Clin Rheumatol 2011;30(1):115-9.
• Ferreira M, Antonio N, Goncalves F, et al. [Hemoglobin: Simply a laboratory value or a powerful predictor of risk in patients with acute coronary syndrome?]. Rev Port Cardiol 2012;31(2):121-31.

Vancouver

Tülübaş F, Gürel A, Akkoyun DC, Alpsoy Ş, Akyüz A, Erdoğan H, et al. MCV and MCH Values in Coronary Artery Patients with Positive Gensini Score. EUR J GEN MED. 2013;10(3):131-5. https://doi.org/10.29333/ejgm/82240

APA

Tülübaş, F., Gürel, A., Akkoyun, D. C., Alpsoy, Ş., Akyüz, A., Erdoğan, H., & Yılmaz, A. (2013). MCV and MCH Values in Coronary Artery Patients with Positive Gensini Score. European Journal of General Medicine, 10(3), 131-135. https://doi.org/10.29333/ejgm/82240

AMA

Tülübaş F, Gürel A, Akkoyun DC, et al. MCV and MCH Values in Coronary Artery Patients with Positive Gensini Score. EUR J GEN MED. 2013;10(3), 131-135. https://doi.org/10.29333/ejgm/82240

Chicago

Tülübaş, Feti, Ahmet Gürel, Dursun Cayan Akkoyun, Şeref Alpsoy, Aydın Akyüz, Hasan Erdoğan, and Ahsen Yılmaz. "MCV and MCH Values in Coronary Artery Patients with Positive Gensini Score". European Journal of General Medicine 2013 10 no. 3 (2013): 131-135. https://doi.org/10.29333/ejgm/82240

Harvard

Tülübaş, F., Gürel, A., Akkoyun, D. C., Alpsoy, Ş., Akyüz, A., Erdoğan, H., and Yılmaz, A. (2013). MCV and MCH Values in Coronary Artery Patients with Positive Gensini Score. European Journal of General Medicine, 10(3), pp. 131-135. https://doi.org/10.29333/ejgm/82240

MLA

Tülübaş, Feti et al. "MCV and MCH Values in Coronary Artery Patients with Positive Gensini Score". European Journal of General Medicine, vol. 10, no. 3, 2013, pp. 131-135. https://doi.org/10.29333/ejgm/82240